Pilomatricoma Localized in the Arm: A Rare Case Report
Journal Title: Open Access Journal of Oncology and Medicine - Year 2018, Vol 1, Issue 4
Abstract
A pilomatricoma is a rare, benign skin tumour originating from the hair follicle cells. It accounts for 0.15 of skin tumours is. It usually involves the head and neck region. The definitive diagnosis is based on histological examination. The recommended treatment is surgical removal of the lesion. Herein, we report a 40-year-old male case of pilomatricoma localized in the arm. We present our case due to its rare occurrence in the arm. Pilomatricoma was first defined by Malherbe and Chenantais in 1880. It is a rare benign soft tissue tumour which is originated from varying stem cells of hair follicles. Earlier, it was known as the calcifying epithelioma of Malherbe and named as pilomatricoma by Forbis and Helwig in 1961[1,2]. The tumour is usually localized under the skin with a slowly growing pattern and presents with firm and and mobile masses. It can be seen as a single nodule; however, multiple pilomatricomas have been also reported [3,4]. More than one lesion can be seen with a ratio of 2 to 10%. Also, malignant forms have been reported. This malignant form is named as Pilomatrix carcinoma and has been shown to metastatize to the lung, bone, brain, skin, lymph nodes, and abdominal organs [5-8]. Pilomatricomas can be seen in women under 20 years of age, particularly, compared to men in a ratio of 3:2(1). It is more common in Caucasians. Familial transmission can be seen and its relation with Gardner syndrome, Steinert disease, and sarcoidosis has been shown [9-11]. For about 50% of pilomatricomas are seen in the head and neck region and, less frequently, in the trunk, arms, and legs [5]. The size of lesion varies from 0.5 to 3cm [12,13].
Authors and Affiliations
Emin Özkul, Mehmet Onur Ziyadanoğulları, Mehmet Fırat Tantekin, Serhat G
Keywords
Related Articles
- EP ID EP586839
- DOI 10.32474/OAJOM.2018.01.000118
- Views 60
- Downloads 0
A Case of Malignant Lymphomas that Healed Completely After Oral Administrations of 4-Hydroxybenzaldehyde
In 1969, Mutsuyuki Kochi [1,2] developed 4-Hydroxybenzaldehyde for use as a novel anti-tumor agent without side effect and acquired its patent. Accordingly, this medicine is capable of preventing carcinogenesis when used...
Aspirin, Vascular Disease and Cancer: 50 Years of Controversy and the Jury’s Still Out!
The story of aspirin and vascular disease starts with John O Brien, a haematologist in Portsmouth in the 1960s, who reported that the ingestion of 150mg of aspirin substantially reduced the aggregation of platelets [1]....
Checkpoint Inhibitors in Squamous Non-Small Cell Lung Cancer (NSCLC)
Checkpoint inhibitors have demonstrated efficacy in squamous NSCLC with tolerable toxicity profile. They are used as a monotherapy, in combination with chemotherapy or following chemo-radiotherapy as a first line, second...
Colorectal Cancer in UAE, Implications on the Screening Program 2018
a) Colorectal cancer is the fourth (4th) common cancer in both sexes, worldwide and is the third most common cancer in men and the second in women. b) In 2012, 1.36 million cases of colorectal cancer occurred and there w...
Promising Role of Fractional Calculus in Biomedicine and Biophysics
The study of complex systems and investigation of their structural and dynamical properties have attracted considerable interests among scientists in general and physicists, biologists and medical researchers in particul...